-
PPMD Hosts Meeting Exploring the Case for Cardiac Transplantation in Duchenne
As part of our ongoing Cardiac Initiative, PPMD is proud to host the upcoming professional […]
-
Capricor to seek deramiocel’s FDA approval for DMD heart disease
Capricor Therapeutics will soon begin filing an application seeking U.S. approval of its cell therapy […]
-
PPMD Joins Duchenne Parent Project aps Respiratory International Professional Care Meeting
Parent Project Muscular Dystrophy (PPMD) is pleased to announce our participation in the upcoming “Respiratory […]
-
MDA Engage offers neuromuscular disease updates, connections
The Muscular Dystrophy Association (MDA) is providing neuromuscular disease (NMD) patients and their families with […]
-
Catch Up on Our PPMD Together Event in Seattle, Washington
This past weekend, PPMD convened over 100 attendees at our PPMD Together event in Seattle, […]
-
Examples of ableism I’ve encountered in life with FSHD
I’ve been disabled for over 50 years, and I spent over 30 years working with […]
-
Positive Interim Data from Wave Life Sciences Exon 53 Skipping Program
CureDuchenne is pleased to communicate that Wave Life Sciences announced positive interim data from the […]
-
Thanks to You PPMD Continues Forward in All Areas of Support
As we celebrate PPMD’s Duchenne Action Month inspired by World Duchenne Awareness Day, we are […]
-
Capricor will file this year for FDA approval of Deramiocel for the treatment of Duchenne cardiomyopathy
As an early investor in Capricor Therapeutics, CureDuchenne is happy to share that Capricor has […]
-
Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Individuals With Duchenne Amenable to Exon 53 Skipping
Wave Life Sciences has announced positive interim data from the ongoing Phase 2 FORWARD-53 study […]
